Black AIDS Institute Applauds FDA Approval Of PrEP

    A single blue Truvada PrEP pill sitting on a white surfaceThe Black AIDS Institute recently announced its support of the FDA’s decision to approve use of the antiretroviral drug Truvada as an option for HIV prevention.

    Gilead Sciences, maker of Truvada, based its application on results of two placebo-controlled trials-iPrEx in men who have sex with men and Partners PrEP in HIV-discordant heterosexual African couples.

    Celebrate great health! LIKE on Facebook!

    1 2 Next page »


    Get every new post delivered to your Inbox.

    Join 945 other followers